The Leukemia & Lymphoma Society Unveils Name Change to Reach All Blood Cancer Patients

WASHINGTON, July 29, 2025 /PRNewswire/ -- The Leukemia & Lymphoma Society (LLS), the global nonprofit in funding blood cancer research, patient support and advocacy, is becoming Blood Cancer United on August 28, in advance of Blood Cancer Awareness Month in September. 

For more than 75 years, LLS has been committed to reaching and supporting the entire blood cancer community—patients, families, caregivers, researchers, healthcare professionals, and partners—including those with blood cancers that aren't leukemia and lymphoma.  With more than 100 types of blood cancers, such as myeloma, myelodysplastic syndromes (MDS), and myeloproliferative neoplasms (MPN), LLS gathered extensive feedback from across its network and determined that now is the time for an evolution—to better reflect the work and unity at the center of its mission.

"We are at a pivotal moment—not only for our organization, but for our community—when funding for cancer research and access to treatment and care are at risk," said E. Anders Kolb, M.D., President and CEO of LLS. "Patients and researchers are telling us they're worried about the impact these changes will have for anyone dealing with blood cancer, so there's no better time for a resource that helps us reach more of the patients who need us.

"The word 'united' is transformational and inviting," added Dr. Kolb. "I believe in the power of bringing together patients, families, scientists, volunteers, donors, business leaders, and health systems under a shared purpose. Blood Cancer United reflects who we are today and who we aspire to be—a unifying force advancing progress for every person impacted by blood cancer."

And when more people can be reached, the organization can get closer to its bold goal: By 2040, we will enable patients with blood cancer to gain more than one million years of life.

New Name, Same Mission

While LLS is evolving its name, the organization will continue to directly help patients by funding promising research, advancing innovative treatments, offering free support, and advocating for policies that help people access quality healthcare.

"This is more than a name change; it's a call to action that's more important than ever to ensure that every patient is seen, supported, and given a chance at life," said Gwen Nichols, M.D., LLS, Chief Medical Officer." Blood Cancer United reflects the strength of an entire community, working together to ensure every person with blood cancer can live a longer, better life - people affected by all 100+ types of blood cancer, beyond leukemia and lymphoma. It sends a powerful message: We are here for you. No blood cancer patient has to go it alone."

Launching for Blood Cancer Awareness Month 2025

Just in time for Blood Cancer Awareness Month this September, LLS will publicly unveil its new name on August 28, 2025. The reveal marks a transformation years in the making—one that promises to reach and unite the blood cancer community and ignite momentum. A new brand identity and campaign rollout will coincide this fall.

About The Leukemia & Lymphoma Society
The Leukemia & Lymphoma Society® (LLS) is the global leader and innovator in creating a world without blood cancer, and the largest nonprofit funder of blood cancer research, investing more than $1.8 billion in the most pioneering science worldwide since 1949. The LLS mission: Cure blood cancer and improve the quality of life of all patients and their families. LLS is focused on accelerating research, providing free support and services, and advocating for policies to ensure access to quality, affordable care. For more than 75 years, LLS has been helping blood cancer patients live longer, better lives.   

To learn more, visit www.LLS.org. Patients can contact the Information Resource Center at (800) 955-4572, Monday through Friday, 9 a.m. to 9 p.m. ET.  Connect with us on Facebook, X, Instagram, LinkedIn and TikTok.

Members of the media seeking more information or an interview, please contact: [email protected]. 

SOURCE The Leukemia & Lymphoma Society (LLS)